<DOC>
	<DOCNO>NCT00499798</DOCNO>
	<brief_summary>RATIONALE : Learning whether temozolomide change semen sperm patient brain tumor may help doctor learn long-term effect treatment plan best treatment . PURPOSE : This clinical trial study change semen sperm cause temozolomide patient newly diagnose , progressive , recurrent primary malignant brain tumor .</brief_summary>
	<brief_title>Changes Semen Sperm Caused Temozolomide Patients With Newly Diagnosed , Progressive , Recurrent Primary Malignant Brain Tumors</brief_title>
	<detailed_description>OBJECTIVES : Primary - Assess temozolomide induces change standard semen sperm analysis parameter ( i.e. , volume , viscosity , pH , forward progression , total count , total motile count , motility , presence round cell , agglutination , morphology ) patient newly diagnose , recurrent , progressive primary malignant brain tumor . OUTLINE : This pilot study . During treatment temozolomide , patient undergo semen sperm sample collection baseline , 3 month , 6 month semen analysis . Samples analyze volume , viscosity , pH , forward progression , total count , total motile count , motility , presence round cell , agglutination , morphology .</detailed_description>
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Brain Neoplasms</mesh_term>
	<mesh_term>Nervous System Neoplasms</mesh_term>
	<mesh_term>Central Nervous System Neoplasms</mesh_term>
	<mesh_term>Temozolomide</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm primary malignant brain tumor Newly diagnose , progressive , recurrent disease May receive prior radiotherapy without chemotherapy Scheduled begin singleagent temozolomide chemotherapy Must able ejaculate Must abstain ejaculating ( e.g. , sex masturbate ) 27 day prior study No know abnormal sperm motility and/or morphology PATIENT CHARACTERISTICS : Karnofsky performance status 60100 % PRIOR CONCURRENT THERAPY : See Disease Characteristics</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>infertility</keyword>
	<keyword>chemotherapeutic agent toxicity</keyword>
	<keyword>adult anaplastic astrocytoma</keyword>
	<keyword>adult diffuse astrocytoma</keyword>
	<keyword>adult giant cell glioblastoma</keyword>
	<keyword>adult gliosarcoma</keyword>
	<keyword>adult pilocytic astrocytoma</keyword>
	<keyword>adult brain stem glioma</keyword>
	<keyword>adult central nervous system germ cell tumor</keyword>
	<keyword>adult choroid plexus tumor</keyword>
	<keyword>adult craniopharyngioma</keyword>
	<keyword>adult ependymoblastoma</keyword>
	<keyword>adult medulloblastoma</keyword>
	<keyword>adult supratentorial primitive neuroectodermal tumor ( PNET )</keyword>
	<keyword>adult anaplastic ependymoma</keyword>
	<keyword>adult ependymoma</keyword>
	<keyword>adult myxopapillary ependymoma</keyword>
	<keyword>adult subependymoma</keyword>
	<keyword>adult anaplastic meningioma</keyword>
	<keyword>meningeal melanocytoma</keyword>
	<keyword>adult meningeal hemangiopericytoma</keyword>
	<keyword>adult papillary meningioma</keyword>
	<keyword>adult grade I meningioma</keyword>
	<keyword>adult grade II meningioma</keyword>
	<keyword>adult grade III meningioma</keyword>
	<keyword>adult anaplastic oligodendroglioma</keyword>
	<keyword>adult oligodendroglioma</keyword>
	<keyword>adult pineoblastoma</keyword>
	<keyword>adult pineocytoma</keyword>
	<keyword>adult mixed glioma</keyword>
	<keyword>recurrent adult brain tumor</keyword>
	<keyword>adult subependymal giant cell astrocytoma</keyword>
</DOC>